About Akoya Biosciences
Akoya Biosciences is a company based in San Francisco (United States) founded in 2015 was acquired by Quanterix in July 2025.. Akoya Biosciences has raised $83.5 million across 4 funding rounds from investors including Agilent, Quanterix and HHS. The company has 649 employees as of December 31, 2022. Akoya Biosciences operates in a competitive market with competitors including Scopio Labs, PreciPoint, Morphle, Optra SCAN and Grundium, among others.
- Headquarter San Francisco, United States
- Employees 649 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
$11.96 M-59as on Dec 31, 2024
-
Net Profit
$-55.37 M13as on Dec 31, 2024
-
EBITDA
$-46.73 M19as on Dec 31, 2024
-
Total Equity Funding
$83.5 M (USD)
in 4 rounds
-
Latest Funding Round
$50 M (USD), Series C
Dec 05, 2019
-
Investors
Agilent
& 5 more
-
Employee Count
649
as on Dec 31, 2022
-
Acquired by
Quanterix
(Jul 09, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Akoya Biosciences
Akoya Biosciences has successfully raised a total of $83.5M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $50.0M
-
First Round
First Round
(14 Jul 2017)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Series C - Akoya Biosciences | Valuation | Piper Jaffray | |
| Sep, 2018 | Amount | Series B - Akoya Biosciences | Valuation |
investors |
|
| Feb, 2018 | Amount | Grant - Akoya Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Akoya Biosciences
Akoya Biosciences has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Agilent, Quanterix and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
Diversified debt funding is provided for growth capital opportunities.
|
Founded Year | Domain | Location | |
|
Middle market focused investment bank
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Akoya Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Akoya Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Akoya Biosciences Comparisons
Competitors of Akoya Biosciences
Akoya Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scopio Labs, PreciPoint, Morphle, Optra SCAN and Grundium, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of computational imaging-based digital microscopes & image analysis tools
|
|
| domain | founded_year | HQ Location |
Digital microscopes and micro-positioning systems are developed.
|
|
| domain | founded_year | HQ Location |
Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.
|
|
| domain | founded_year | HQ Location |
Integrated digital pathology solutions.
|
|
| domain | founded_year | HQ Location |
Portable scanning microscopes are supplied for medical researchers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Akoya Biosciences
Frequently Asked Questions about Akoya Biosciences
When was Akoya Biosciences founded?
Akoya Biosciences was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Akoya Biosciences located?
Akoya Biosciences is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Akoya Biosciences a funded company?
Akoya Biosciences is a funded company, having raised a total of $83.5M across 4 funding rounds to date. The company's 1st funding round was a Grant of $149.55K, raised on Jul 14, 2017.
How many employees does Akoya Biosciences have?
As of Dec 31, 2022, the latest employee count at Akoya Biosciences is 649.
What is the annual revenue of Akoya Biosciences?
Annual revenue of Akoya Biosciences is $11.96M as on Dec 31, 2024.
What does Akoya Biosciences do?
Akoya Biosciences was founded in 2015 and is headquartered in San Francisco, United States. The company operates in the biotechnology sector, focusing on proteomic analysis tools. Its CODEX platform is utilized for co-detection by indexing, allowing multiple antibodies to be labeled in a single assay through tagged oligonucleotides and fluorescence imaging. This enables in situ deep profiling of tissue organization, with applications in immunology and oncology research.
Who are the top competitors of Akoya Biosciences?
Akoya Biosciences's top competitors include Optra SCAN, Scopio Labs and Morphle.
Who are Akoya Biosciences's investors?
Akoya Biosciences has 6 investors. Key investors include Agilent, Quanterix, HHS, Piper Jaffray, and Telegraph Hill Partners.